Source: European Parliament
Question for written answer E-002696/2025
to the Commission
Rule 144
Anja Hazekamp (The Left)
Amid ongoing safety concerns, glyphosate remains the most widely used pesticide in the EU. In 2015, the International Agency for Research on Cancer found glyphosate to be carcinogenic to animals and probably to humans[1]. A Parliament appeal to ban glyphosate was ignored[2].
The Commission has stated ‘if evidence emerges that indicates that the approval criteria are no longer fulfilled, a review of the approval at EU level may be initiated at any time and the Commission will take action immediately to amend or withdraw the approval if this is scientifically warranted’[3].
Now, a new Environmental Health study confirms that glyphosate has probable carcinogenic effects after long-term exposure to ‘safe’ doses[4].
Considering these findings:
- 1.Does the Commission maintain its claim that using glyphosate until 2033 is safe, and if so, how is this assessment justified?
- 2.What steps will it take in response to the study, for example, is it willing to immediately trigger a review of the approval, as provided for in Article 21 of Regulation (EC) No 1107/2009, as the study suggests glyphosate meets the cut-off criteria, and to prepare an immediate withdrawal of the approval?
- 3.Why does the Commission prioritise uncritical, industry-financed studies over impartial research?
Submitted: 2.7.2025
- [1] https://www.iarc.who.int/news-events/glyphosate-monograph-now-available/.
- [2] https://www.europarl.europa.eu/doceo/document/TA-8-2017-0395_EN.html.
- [3] https://ec.europa.eu/commission/presscorner/detail/en/qanda_23_5793.
- [4] https://ehjournal.biomedcentral.com/articles/10.1186/s12940-025-01187-2.